FAPI PET cancer imaging fibroblast activation protein sarcoma

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
01 2022
Historique:
received: 08 02 2021
revised: 13 04 2021
pubmed: 2 5 2021
medline: 19 2 2022
entrez: 1 5 2021
Statut: ppublish

Résumé

Bone and soft-tissue sarcomas express fibroblast activation protein (FAP) on tumor cells and associated fibroblasts. Therefore, FAP is a promising therapeutic and diagnostic target. Novel radiolabeled FAP inhibitors (e.g.,

Identifiants

pubmed: 33931468
pii: jnumed.121.262096
doi: 10.2967/jnumed.121.262096
pmc: PMC8717183
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-95

Informations de copyright

© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Références

J Nucl Med. 2018 Sep;59(9):1415-1422
pubmed: 29626119
J Nucl Med. 2018 Sep;59(9):1423-1429
pubmed: 29626120
J Nucl Med. 2020 Dec;61(12):1793-1799
pubmed: 32358094
Sarcoma. 2010;2010:506182
pubmed: 20634933
J Nucl Med. 2021 Jun 1;62(6):779-786
pubmed: 33097632
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5657-61
pubmed: 7911242
PLoS One. 2015 Mar 16;10(3):e0116683
pubmed: 25775399
Ann Rheum Dis. 2020 Nov;79(11):1485-1491
pubmed: 32719042
Int J Cancer. 2001 Jan 20;95(1):67-72
pubmed: 11241314
J Nucl Med. 2003 May;44(5):717-24
pubmed: 12732672
Proc Natl Acad Sci U S A. 1988 May;85(9):3110-4
pubmed: 2896356
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1820-1832
pubmed: 32222810
Cancer Lett. 2003 Sep 10;199(1):91-8
pubmed: 12963128
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1593-1603
pubmed: 33097975
Clin Cancer Res. 1998 May;4(5):1215-20
pubmed: 9607579
J Nucl Med. 2017 Nov;58(11):1793-1796
pubmed: 28473600
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2569-2580
pubmed: 31388723
J Nucl Med. 2019 Oct;60(10):1421-1429
pubmed: 30850501
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):73-86
pubmed: 32588089
Int J Dev Biol. 2001 Apr;45(2):445-7
pubmed: 11330865
J Clin Med. 2020 Aug 06;9(8):
pubmed: 32781683
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):3011-3013
pubmed: 33728499
J Nucl Med. 2019 Mar;60(3):386-392
pubmed: 30072500
Curr Mol Med. 2012 Dec;12(10):1220-43
pubmed: 22834826
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
Histopathology. 2009 Oct;55(4):432-40
pubmed: 19817894
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):942-944
pubmed: 32783111
Clin Nucl Med. 2020 Apr;45(4):310-311
pubmed: 31977474
Mol Oncol. 2016 Jan;10(1):40-58
pubmed: 26304112
Int Rev Cell Mol Biol. 2012;297:83-116
pubmed: 22608558
Clin Cancer Res. 2007 Mar 15;13(6):1736-41
pubmed: 17363526

Auteurs

Lukas Kessler (L)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.

Justin Ferdinandus (J)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.

Nader Hirmas (N)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.

Sebastian Bauer (S)

German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.

Uta Dirksen (U)

German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.
Department of Pediatrics III, West German Cancer Center, University Hospital Essen, Essen, Germany.

Fadi Zarrad (F)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.

Michael Nader (M)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.

Michal Chodyla (M)

German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.

Aleksandar Milosevic (A)

German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.

Lale Umutlu (L)

German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.
Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany.

Martin Schuler (M)

German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.

Lars Erik Podleska (LE)

German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.
Department of Tumor Orthopedics and Sarcoma Surgery, University Hospital Essen, Essen, Germany; and.

Hans-Ulrich Schildhaus (HU)

German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.
Department of Pathology, University Hospital Essen, Essen, Germany.

Wolfgang P Fendler (WP)

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany; wolfgang.fendler@uk-essen.de.
German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.

Rainer Hamacher (R)

German Cancer Consortium, Partner Site University Hospital Essen, and German Cancer Research Center, Essen, Germany.
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.

Articles similaires

Anhui Zhu, Xiaoyan Hou, Na Guo et al.
1.00
Humans Carcinoma, Renal Cell Vena Cava, Inferior Male Female
Humans B7-H1 Antigen Positron Emission Tomography Computed Tomography Esophageal Squamous Cell Carcinoma Fluorodeoxyglucose F18
Humans Carcinoma, Non-Small-Cell Lung Male Fluorodeoxyglucose F18 Female

Assessing the metabolism of the olfactory circuit by use of

Daniël S L Loewenstein, Max van Grinsven, Cécile de Pont et al.
1.00
Humans Alzheimer Disease Frontotemporal Dementia Fluorodeoxyglucose F18 Male

Classifications MeSH